• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化和 MELD 评分对肝切除患者术后发病率和死亡率的影响。

The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection.

机构信息

Department of Surgery, University of Virginia, Charlottesville, VA, USA; Surgical Outcomes Research Center, University of Virginia, Charlottesville, VA, USA; Section of Hepatobiliary and Pancreatic Surgery, University of Virginia, Charlottesville, VA, USA.

Department of Surgery, University of Virginia, Charlottesville, VA, USA; Surgical Outcomes Research Center, University of Virginia, Charlottesville, VA, USA.

出版信息

Am J Surg. 2020 Sep;220(3):682-686. doi: 10.1016/j.amjsurg.2020.01.022. Epub 2020 Jan 20.

DOI:10.1016/j.amjsurg.2020.01.022
PMID:31983407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7369232/
Abstract

BACKGROUND

Independent associations between chronic liver disease, MELD, and postoperative outcomes among patients selected for liver resection have not been completely established. We hypothesized independent associations between MELD, cirrhosis, and postoperative mortality.

METHODS

Patient-level data from the targeted hepatectomy module and ACS NSQIP PUF during 2014-2015 were merged. Multivariable regression models with interaction effect between MELD and liver texture (normal, congested/fatty, cirrhotic) tested the independent effects of covariates on mortality and morbidity.

RESULTS

3,530 patients were included, of whom 668 patients (19%) had cirrhosis. ACS NSQIP defined mortality (3.9%vs1.1%) and morbidity (23.5%vs15.8%) were higher in patients with cirrhosis (both p < 0.001). In multivariable models, cirrhosis (OR = 2.24; 95%CI:1.16-4.34, p = 0.016) and MELD (OR = 1.10; 95%CI:1.03-1.18, p = 0.007) were independently associated with mortality. MELD (OR = 1.04; 95%CI:1.002-1.08, p = 0.038) was associated with postoperative morbidity.

CONCLUSIONS

Higher MELD and presence of cirrhosis have an independent negative effect on mortality after liver resection. MELD could be used to estimate postoperative risk in patients with and without cirrhosis.

摘要

背景

慢性肝病、MELD 评分和肝切除术患者术后结局之间的独立关联尚未完全确定。我们假设 MELD、肝硬化与术后死亡率之间存在独立关联。

方法

合并了 2014-2015 年靶向肝切除术模块和 ACS NSQIP PUF 的患者水平数据。多变量回归模型中,MELD 与肝脏质地(正常、充血/脂肪、肝硬化)之间存在交互效应,用于测试协变量对死亡率和发病率的独立影响。

结果

共纳入 3530 例患者,其中 668 例(19%)患有肝硬化。ACS NSQIP 定义的死亡率(3.9%比 1.1%)和发病率(23.5%比 15.8%)在肝硬化患者中更高(均 p<0.001)。多变量模型中,肝硬化(OR=2.24;95%CI:1.16-4.34,p=0.016)和 MELD(OR=1.10;95%CI:1.03-1.18,p=0.007)与死亡率独立相关。MELD(OR=1.04;95%CI:1.002-1.08,p=0.038)与术后发病率相关。

结论

较高的 MELD 和肝硬化的存在对肝切除术后的死亡率有独立的负面影响。MELD 可用于估计有无肝硬化患者的术后风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67bc/7369232/4a36b4f5b26b/nihms-1551637-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67bc/7369232/4a36b4f5b26b/nihms-1551637-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67bc/7369232/4a36b4f5b26b/nihms-1551637-f0001.jpg

相似文献

1
The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection.肝硬化和 MELD 评分对肝切除患者术后发病率和死亡率的影响。
Am J Surg. 2020 Sep;220(3):682-686. doi: 10.1016/j.amjsurg.2020.01.022. Epub 2020 Jan 20.
2
Comparing Outcomes of Minimally Invasive and Open Hepatectomy for Primary Liver Malignancies in Patients with Low-MELD Cirrhosis.低MELD评分肝硬化患者原发性肝癌行微创与开放肝切除术的疗效比较
J Gastrointest Surg. 2023 Nov;27(11):2424-2433. doi: 10.1007/s11605-023-05817-3. Epub 2023 Aug 24.
3
The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.慢性肝病对肝切除术后ACS NSQIP发病率和死亡率风险评估的影响。
Surgery. 2016 May;159(5):1308-15. doi: 10.1016/j.surg.2015.11.020. Epub 2015 Dec 31.
4
Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.终末期肝病模型评分无法预测无肝硬化的肝细胞癌患者肝切除术后的围手术期结局。
Am J Surg. 2008 May;195(5):697-701. doi: 10.1016/j.amjsurg.2007.05.054.
5
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.终末期肝病模型(MELD)评分对肝硬化合并肝细胞癌肝切除术后预后的影响。
Liver Transpl. 2006 Jun;12(6):966-71. doi: 10.1002/lt.20761.
6
Esophageal Cancer Surgery for Patients with Concomitant Liver Cirrhosis: A Single-Center Matched-Cohort Study.伴有肝硬化患者的食管癌手术:一项单中心匹配队列研究
Ann Surg Oncol. 2017 Mar;24(3):763-769. doi: 10.1245/s10434-016-5610-8. Epub 2016 Oct 4.
7
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.建立预测 Child-Pugh B 级肝硬化肝癌患者肝切除术后结局的列线图。
J Hepatol. 2020 Jan;72(1):75-84. doi: 10.1016/j.jhep.2019.08.032. Epub 2019 Sep 6.
8
Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites.终末期肝病模型钠作为腹水肝硬化患者手术风险的预测因子。
J Surg Res. 2020 Jun;250:45-52. doi: 10.1016/j.jss.2019.12.037. Epub 2020 Feb 1.
9
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.肝癌切除术后肝失代偿相关因素的层次交互作用。
JAMA Surg. 2016 Sep 1;151(9):846-53. doi: 10.1001/jamasurg.2016.1121.
10
The utility of the MELD score in predicting mortality following liver resection for metastasis.终末期肝病模型(MELD)评分在预测肝转移瘤切除术后死亡率方面的效用。
Eur J Surg Oncol. 2016 Oct;42(10):1568-75. doi: 10.1016/j.ejso.2016.05.035. Epub 2016 Jun 16.

引用本文的文献

1
Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery.可溶性触发受体2反映肝纤维化状态并预测肝脏手术后的术后肝功能障碍。
JHEP Rep. 2024 Oct 4;7(4):101226. doi: 10.1016/j.jhepr.2024.101226. eCollection 2025 Apr.
2
Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.丙型肝炎病毒相关肝内胆管癌肝切除的结果:一项系统评价和荟萃分析。
World J Virol. 2024 Mar 25;13(1):88946. doi: 10.5501/wjv.v13.i1.88946.
3
Developing and validating a nomogram based on skeletal muscle index and clinical scoring system for prediction of liver failure after hepatectomy.

本文引用的文献

1
Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.肝门部胆管癌患者行大肝切除术后的发病率和死亡率:系统评价和荟萃分析。
Surgery. 2019 May;165(5):918-928. doi: 10.1016/j.surg.2019.01.010. Epub 2019 Mar 11.
2
Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease.肝硬化患者的非肝脏腹部手术。
J Gastrointest Surg. 2019 Mar;23(3):634-642. doi: 10.1007/s11605-018-3991-7. Epub 2018 Nov 21.
3
Effects of patient factors on inpatient mortality after complex liver, pancreatic and gastric resections.
基于骨骼肌指数和临床评分系统开发并验证用于预测肝切除术后肝衰竭的列线图。
Front Oncol. 2023 Jan 19;13:1036921. doi: 10.3389/fonc.2023.1036921. eCollection 2023.
4
Predictors of Liver Failure in Non-Cirrhotic Patients Undergoing Hepatectomy.非肝硬化患者行肝切除术的肝衰竭预测因素。
World J Surg. 2022 Dec;46(12):3081-3089. doi: 10.1007/s00268-022-06742-3. Epub 2022 Oct 8.
5
Performance of risk prediction models for post-operative mortality in patients undergoing liver resection.肝切除术患者术后死亡率风险预测模型的性能。
Am J Surg. 2023 Jan;225(1):198-205. doi: 10.1016/j.amjsurg.2022.07.028. Epub 2022 Aug 5.
6
A Novel Predictive Scoring System for 90-Day Mortality among Patients with Hepatocellular Cell Carcinoma Receiving Major Hepatectomy.一种用于接受大肝切除术的肝细胞癌患者90天死亡率的新型预测评分系统。
Cancers (Basel). 2022 Mar 9;14(6):1398. doi: 10.3390/cancers14061398.
7
A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma.一种用于预测巨大肝细胞癌肝切除术后90天死亡率的新型术前预测模型。
Ann Transl Med. 2021 May;9(9):774. doi: 10.21037/atm-20-7842.
8
Prognostic role of preoperative albumin-bilirubin score in posthepatectomy liver failure and mortality: a systematic review and meta-analysis.术前白蛋白-胆红素评分在肝切除术后肝功能衰竭和死亡率中的预后作用:系统评价和荟萃分析。
Updates Surg. 2022 Jun;74(3):821-831. doi: 10.1007/s13304-021-01080-w. Epub 2021 May 19.
患者因素对复杂肝脏、胰腺和胃部切除术后住院死亡率的影响。
BJS Open. 2018 Mar 15;1(6):191-201. doi: 10.1002/bjs5.33. eCollection 2017 Dec.
4
Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant.肝门部胆管癌肝切除术后的死亡率:风险评分的制定及未来肝残余量胆汁引流的重要性
J Am Coll Surg. 2016 Aug;223(2):321-331.e1. doi: 10.1016/j.jamcollsurg.2016.03.035. Epub 2016 Apr 5.
5
The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.慢性肝病对肝切除术后ACS NSQIP发病率和死亡率风险评估的影响。
Surgery. 2016 May;159(5):1308-15. doi: 10.1016/j.surg.2015.11.020. Epub 2015 Dec 31.
6
Morbidity and mortality of hepatectomy for benign liver tumors.良性肝肿瘤肝切除术的发病率和死亡率。
Am J Surg. 2016 Jan;211(1):102-8. doi: 10.1016/j.amjsurg.2015.06.010. Epub 2015 Jul 31.
7
A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis.肝硬化患者减重手术的系统评价
Obes Surg. 2015 Aug;25(8):1518-26. doi: 10.1007/s11695-015-1727-2.
8
Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score.根据Child-Pugh评分对肝硬化患者心脏手术后的死亡率进行分类。
Interact Cardiovasc Thorac Surg. 2015 Apr;20(4):520-30. doi: 10.1093/icvts/ivu438. Epub 2015 Jan 22.
9
Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons.开发和评估通用 ACS NSQIP 手术风险计算器:为患者和外科医生提供的决策辅助和知情同意工具。
J Am Coll Surg. 2013 Nov;217(5):833-42.e1-3. doi: 10.1016/j.jamcollsurg.2013.07.385. Epub 2013 Sep 18.
10
Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients.老年患者肝切除术后发病率和死亡率的预测因素:7621 例 NSQIP 患者的分析。
HPB (Oxford). 2014 May;16(5):459-68. doi: 10.1111/hpb.12155. Epub 2013 Aug 26.